Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)
Clinical trial NCT01274559 · TERMINATED
Trial details
- NCT number
- NCT01274559
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-02-26
- Enrollment
- 1173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.